Cell and Gene Supply Chain Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Applications, By End User Region and Competition, 2020-2030F

Description

The Global Cell and Gene Supply Chain Services Market , valued at USD 1.44 Billion in 2024, is projected to experience a CAGR of 9.85% to reach USD 2.53 Billion by 2030. The Global Cell and Gene Supply Chain Services Market involves the specialized logistics, handling, and controlled storage necessary for transporting sensitive cell and gene therapies, ensuring product integrity from patient sample collection through to administration. The market's growth is predominantly supported by the increasing number of these advanced therapies progressing through clinical trials and receiving regulatory approvals, coupled with significant investments in biopharmaceutical innovation.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.44 Billion
Market Size 2030	USD 2.53 Billion
CAGR 2025-2030	9.85%
Fastest Growing Segment	Logistics
Largest Market	North America

Key Market Drivers

Advancements in cell and gene therapy technologies significantly influence the supply chain services market by introducing novel logistical complexities. The evolution of gene editing tools and advanced delivery systems enables precise genetic modifications and expanded therapeutic applications, necessitating highly specialized cold chain management and transport.

Key Market Challenges

The intricate requirement for establishing and maintaining a robust, globally integrated cryogenic logistics infrastructure presents a significant impediment to the Global Cell and Gene Supply Chain Services Market. These advanced therapies demand ultra-cold storage and precise, uninterrupted temperature-controlled transportation to preserve product integrity from patient sample collection through final administration. The technical complexity and specialized equipment necessary for such rigorous cold chain management across diverse geographic regions create substantial operational hurdles for service providers.

Key Market Trends

Enhanced Digital Traceability and Supply Chain Optimization focuses on leveraging advanced technologies to achieve real-time visibility and control across the entire supply chain. Given the personalized and time-sensitive nature of cell and gene therapies, accurate tracking of materials from patient sample collection to administration is paramount for maintaining product integrity and patient safety. Digitalization and real-time tracking technologies can significantly minimize supply chain risks by enhancing product visibility throughout the value chain.

Key Market Players

Biocair International Limited
Arvato SE
Associated Couriers, LLC.
TrakCel Limited
Parkoursc Inc.
DHL
McKesson Corporation
Almac Group Limited
Catalent Inc.
Biostor Ltd.

Report Scope:

In this report, the Global Cell and Gene Supply Chain Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell and Gene Supply Chain Services Market , By Technology:

Presence on cloud
Presence on-premises

Cell and Gene Supply Chain Services Market , By Applications:

Ordering and scheduling
Sample collection
Logistics
Post treatment follow-up

Cell and Gene Supply Chain Services Market , By End-User:

Biobank/ cell-bank
Hospitals
Research institutes
Cell therapy labs
Others

Cell and Gene Supply Chain Services Market , By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell and Gene Supply Chain Services Market .

Available Customizations:

Global Cell and Gene Supply Chain Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell and Gene Supply Chain Services Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Technology (Presence on cloud, Presence on-premises)
- 5.2.2. By Applications (Ordering and scheduling, Sample collection, Logistics, Post treatment follow-up)
- 5.2.3. By End-User (Biobank/ cell-bank, Hospitals, Research institutes, Cell therapy labs, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Cell and Gene Supply Chain Services Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Technology
- 6.2.2. By Applications
- 6.2.3. By End-User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Cell and Gene Supply Chain Services Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Technology
    - 6.3.1.2.2. By Applications
    - 6.3.1.2.3. By End-User
- 6.3.2. Canada Cell and Gene Supply Chain Services Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Technology
    - 6.3.2.2.2. By Applications
    - 6.3.2.2.3. By End-User
- 6.3.3. Mexico Cell and Gene Supply Chain Services Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Technology
    - 6.3.3.2.2. By Applications
    - 6.3.3.2.3. By End-User

7. Europe Cell and Gene Supply Chain Services Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Technology
- 7.2.2. By Applications
- 7.2.3. By End-User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Cell and Gene Supply Chain Services Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Technology
    - 7.3.1.2.2. By Applications
    - 7.3.1.2.3. By End-User
- 7.3.2. France Cell and Gene Supply Chain Services Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Technology
    - 7.3.2.2.2. By Applications
    - 7.3.2.2.3. By End-User
- 7.3.3. United Kingdom Cell and Gene Supply Chain Services Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Technology
    - 7.3.3.2.2. By Applications
    - 7.3.3.2.3. By End-User
- 7.3.4. Italy Cell and Gene Supply Chain Services Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Technology
    - 7.3.4.2.2. By Applications
    - 7.3.4.2.3. By End-User
- 7.3.5. Spain Cell and Gene Supply Chain Services Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Technology
    - 7.3.5.2.2. By Applications
    - 7.3.5.2.3. By End-User

8. Asia Pacific Cell and Gene Supply Chain Services Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Technology
- 8.2.2. By Applications
- 8.2.3. By End-User
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Cell and Gene Supply Chain Services Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Technology
    - 8.3.1.2.2. By Applications
    - 8.3.1.2.3. By End-User
- 8.3.2. India Cell and Gene Supply Chain Services Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Technology
    - 8.3.2.2.2. By Applications
    - 8.3.2.2.3. By End-User
- 8.3.3. Japan Cell and Gene Supply Chain Services Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Technology
    - 8.3.3.2.2. By Applications
    - 8.3.3.2.3. By End-User
- 8.3.4. South Korea Cell and Gene Supply Chain Services Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Technology
    - 8.3.4.2.2. By Applications
    - 8.3.4.2.3. By End-User
- 8.3.5. Australia Cell and Gene Supply Chain Services Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Technology
    - 8.3.5.2.2. By Applications
    - 8.3.5.2.3. By End-User

9. Middle East & Africa Cell and Gene Supply Chain Services Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Technology
- 9.2.2. By Applications
- 9.2.3. By End-User
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Cell and Gene Supply Chain Services Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Technology
    - 9.3.1.2.2. By Applications
    - 9.3.1.2.3. By End-User
- 9.3.2. UAE Cell and Gene Supply Chain Services Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Technology
    - 9.3.2.2.2. By Applications
    - 9.3.2.2.3. By End-User
- 9.3.3. South Africa Cell and Gene Supply Chain Services Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Technology
    - 9.3.3.2.2. By Applications
    - 9.3.3.2.3. By End-User

10. South America Cell and Gene Supply Chain Services Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Technology
- 10.2.2. By Applications
- 10.2.3. By End-User
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Cell and Gene Supply Chain Services Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Technology
    - 10.3.1.2.2. By Applications
    - 10.3.1.2.3. By End-User
- 10.3.2. Colombia Cell and Gene Supply Chain Services Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Technology
    - 10.3.2.2.2. By Applications
    - 10.3.2.2.3. By End-User
- 10.3.3. Argentina Cell and Gene Supply Chain Services Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Technology
    - 10.3.3.2.2. By Applications
    - 10.3.3.2.3. By End-User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Cell and Gene Supply Chain Services Market : SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Biocair International Limited
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Arvato SE
15.3. Associated Couriers, LLC.
15.4. TrakCel Limited
15.5. Parkoursc Inc.
15.6. DHL
15.7. McKesson Corporation
15.8. Almac Group Limited
15.9. Catalent Inc.
15.10. Biostor Ltd.